Back to School: How biopharma can reboot drug development. Access exclusive analysis here

DM-71: Phase II data

In a Canadian Phase II trial in 55 evaluable patients, oral DM-71

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE